A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Daryl Gioffre, a gut health specialist and celebrity nutritionist in New York who started the internal shower trend on TikTok, said an estimated 42 million Americans are suffering from constipation, ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

No AI company scored better than “weak” in SaferAI’s assessment of their risk management maturity. The highest scorer was ...

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

Expanding on guidance issued a dozen years ago, the U.S. FDA released a draft guidance to help sponsors developing cancer drugs for use in novel combinations determine the contribution of the ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Now, after setting an innovative medicines sales record in the year’s second quarter, it appears J&J’s confidence was well placed.

Elon Musk said Tesla will hold a shareholder vote on whether to invest in xAI. Musk said in March that xAI was valued at $80 billion. The company raised $10 billion last month. SpaceX is looking to ...